Cargando…

Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review

Coronavirus-2019 disease is a newly diagnosed infectious disease, which is caused by the severe acute respiratory syndrome corona virus-2. It spreads quickly and has become a major public health problem throughout the world. When the viral structural spike protein binds to the angiotensin-converting...

Descripción completa

Detalles Bibliográficos
Autor principal:	Adugna, Dagnew Getnet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590837/ https://www.ncbi.nlm.nih.gov/pubmed/34785907 http://dx.doi.org/10.2147/SCCAA.S333800

Ejemplares similares

Therapeutic Application of Stem Cells in the Repair of Traumatic Brain Injury
por: Adugna, Dagnew Getnet, et al.
Publicado: (2022)

Prevalence and associated risk factors of preterm birth among neonates in referral hospitals of Amhara Region, Ethiopia
por: Adugna, Dagnew Getnet
Publicado: (2022)

Maternal and neonatal factors associated with low birth weight among neonates delivered at the University of Gondar comprehensive specialized hospital, Northwest Ethiopia
por: Adugna, Dagnew Getnet, et al.
Publicado: (2022)

HIV testing and associated factors among men (15-64 years) in Eastern Africa: a multilevel analysis using the recent demographic and health survey
por: Adugna, Dagnew Getnet, et al.
Publicado: (2022)

Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021)

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021)

Prevalence and Associated Factors of Macrosomia Among Newborns Delivered in University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia: An Institution-Based Cross-Sectional Study
por: Adugna, Dagnew Getnet, et al.
Publicado: (2020)

Hearing loss and its associated factors among metal workshop workers at Gondar city, Northwest Ethiopia
por: Melese, Mihret, et al.
Publicado: (2022)

Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
por: Xiao, Kun, et al.
Publicado: (2020)

Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
por: Tang, Lingling, et al.
Publicado: (2020)

Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
por: Chen, Lijun, et al.
Publicado: (2022)

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
por: Shu, Lei, et al.
Publicado: (2020)

Mesenchymal stem cell treatment for COVID-19
por: Xu, Ruonan, et al.
Publicado: (2022)

Mesenchymal Stem Cells in the Treatment of COVID-19
por: Guo, Bei-Cyuan, et al.
Publicado: (2023)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
por: Javed, Amaan, et al.
Publicado: (2022)

Clinical applications of mesenchymal stem cells
por: Wang, Shihua, et al.
Publicado: (2012)

Clinical applications of mesenchymal stem cells
por: Kim, Nayoun, et al.
Publicado: (2013)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey
por: O. Ercelen, Nesrin, et al.
Publicado: (2021)

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
por: Sadeghi, Somaye, et al.
Publicado: (2020)

Safety of Mesenchymal Stem Cells for Clinical Application
por: Wang, Youwei, et al.
Publicado: (2012)

Taming of Covid-19: potential and emerging application of mesenchymal stem cells
por: Najafi-Ghalehlou, Nima, et al.
Publicado: (2021)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report
por: Primorac, Dragan, et al.
Publicado: (2021)

Prevalence of Diarrhea, Intestinal Parasites, and Associated Factors Among Under-Five Children in Dabat District, Northwest Ethiopia: Multicenter Cross-sectional Study
por: Melese, Mihret, et al.
Publicado: (2023)

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
por: Gupta, Ashim, et al.
Publicado: (2020)

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
por: Abdelgawad, Mai, et al.
Publicado: (2021)

Mesenchymal stem cell research progress for the treatment of COVID-19
por: Yao, Dezhi, et al.
Publicado: (2020)

Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications
por: Lopez-Santalla, Mercedes, et al.
Publicado: (2020)

Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
por: Yao, Weiqi, et al.
Publicado: (2022)

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
por: Wang, Li-Tzu, et al.
Publicado: (2016)

Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
por: Margiana, Ria, et al.
Publicado: (2022)

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
por: Ghannam, Soufiane, et al.
Publicado: (2010)

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases
por: Farini, Andrea, et al.
Publicado: (2014)

Hematopoietic and Mesenchymal Stem Cells in Biomedical and Clinical Applications
por: Rizvanov, Albert A., et al.
Publicado: (2016)

Clinical application of mesenchymal stem cells in rheumatic diseases
por: Wang, Yajing, et al.
Publicado: (2021)

Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up()
por: Saleh, Mahshid, et al.
Publicado: (2022)

Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
por: Chaudhary, Jitendra Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v03csgtdvoo8vgnauk2kd1kh9r